Literature DB >> 31193687

Author's Reply: Recently introduced thrombolytic therapy regimens have been sufficiently effective and safer in patients with prosthetic valve thrombosis.

Diego Araiza-Garaygordobil1.   

Abstract

Entities:  

Year:  2018        PMID： 31193687      PMCID： PMC6538842          DOI： 10.1016/j.jccase.2018.11.003

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN： 1878-5409


× No keyword cloud information.
  2 in total

1.  Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial.

Authors:  Mehmet Özkan; Sabahattin Gündüz; Ozan Mustafa Gürsoy; Süleyman Karakoyun; Mehmet Ali Astarcıoğlu; Macit Kalçık; Ahmet Çağrı Aykan; Beytullah Çakal; Zübeyde Bayram; Ali Emrah Oğuz; Emre Ertürk; Mahmut Yesin; Tayyar Gökdeniz; Nilüfer Ekşi Duran; Mustafa Yıldız; Ali Metin Esen
Journal:  Am Heart J       Date:  2015-05-02       Impact factor: 4.749

2.  Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial.

Authors:  Mehmet Özkan; Sabahattin Gündüz; Murat Biteker; Mehmet Ali Astarcioglu; Cihan Çevik; Evren Kaynak; Mustafa Yıldız; Emrah Oğuz; Ahmet Çağrı Aykan; Emre Ertürk; Yusuf Karavelioğlu; Tayyar Gökdeniz; Hasan Kaya; Ozan Mustafa Gürsoy; Beytullah Çakal; Süleyman Karakoyun; Nilüfer Duran; Nihal Özdemir
Journal:  JACC Cardiovasc Imaging       Date:  2013-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.